Latest news
Loading news…
Allogenica
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Lyon, Rhone-Alpes, France Founded 2022 11-50 employees For Profit
Allogenica develops allogenic CAR-T cells using donor stem cells for cancer treatment.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
1
Patents
0
1 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 34
- Patents granted
- 0
- Trademarks
- 1
- IT spend
- $9M
Company Info
- Founded
- 2022
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 4
- HQ
- Lyon, Rhone-Alpes, France
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0.4
- Trend (30d)
- -0.2
- Trend (90d)
- -0.6
Key People at Allogenica
CEO & Co-founder
CSO
1
professional contacts at Allogenica
Contact execs at Allogenica →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Allogenica
Loading news…
FAQs about Allogenica
People who checked this page also checked these
Browse the full Acquirezy directory.